Dana-Farber President and CEO Edward J. Benz, Jr, MD, has announced he will retire from the Dana-Farber Cancer Institute (DFCI) in 2016, after 16 years running the organization.
Dr. Benz will also vacate the positions as Director and Principal Investigator of the Dana-Farber/Harvard Cancer Center and Trustee of Dana-Farber/Children’s Hospital Cancer Care.
He will remain Professor of Medicine, Pediatrics, and Genetics at Harvard Medical School and will focus full-time on his research.
Under Dr. Benz’s leadership, Dana-Farber has tripled in size. Annual giving has grown from $50 million to $200 million, and revenue has tripled to roughly $1.1 billion. Dana-Farber’s workforce and patient volume have also tripled in the interim. ■
